Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Itay Lotan

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Muscle & Nerve|March 8, 2026
Increased Prevalence of Extrathymic Neoplasms in Myasthenia Gravis Patients-A Population-Based, Matched Case-Control StudyKeshet Pardo, Tasneem Kab, Mark A Hellmann, et al.
Scientific Reports|February 7, 2024
Anti-aquaporin-4 immune complex stimulates complement-dependent Th17 cytokine release in neuromyelitis optica spectrum disordersShuhei Nishiyama, Jin Myong Seok, Amy E Wright, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 18, 2024
Clinical Characterization and Prognostic Risk Factors of Susac Syndrome: A Retrospective Multicenter StudyLior Fuchs, Adi Wilf-Yarkoni, Hadar Kolb, et al.
Scientific Reports|December 9, 2022
Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritisHadas Stiebel-Kalish, Kerstin Rubarth, Karny Shouchane-Blum, et al.
Plos One|December 7, 2023
Effectiveness of oral prednisone tapering following intravenous methylprednisolone for acute optic neuritis in multiple sclerosisAdi Wilf-Yarkoni, Kristina Feldmann, Kerstin Rubarth, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 11, 2023
Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody diseaseItay Lotan, John J Chen, Yael Hacohen, et al.
Multiple Sclerosis and Related Disorders|July 25, 2025
Relapse and disability outcomes in incident MOGAD patients undergoing watchful waiting after onsetNanthaya Tisavipat, Adi Wilf-Yarkoni, Abdullah Al-Ani, et al.
Multiple Sclerosis and Related Disorders|October 17, 2022
Details and outcomes of a large cohort of MOG-IgG associated optic neuritisJohn J Chen, Eoin P Flanagan, M Tariq Bhatti, et al.
Frontiers in Immunology|July 18, 2024
Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT)Sara Samadzadeh, Rafl Adnan, Paulina Berglova, et al.
Multiple Sclerosis and Related Disorders|January 17, 2022
OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody-associated disease and Multiple Sclerosis: RNFL thickening in acute optic neuritis from MOGAD vs MSJohn J Chen, Elias S Sotirchos, Amanda D Henderson, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Muscle & Nerve|March 8, 2026
Increased Prevalence of Extrathymic Neoplasms in Myasthenia Gravis Patients-A Population-Based, Matched Case-Control StudyKeshet Pardo, Tasneem Kab, Mark A Hellmann, et al.
Scientific Reports|February 7, 2024
Anti-aquaporin-4 immune complex stimulates complement-dependent Th17 cytokine release in neuromyelitis optica spectrum disordersShuhei Nishiyama, Jin Myong Seok, Amy E Wright, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 18, 2024
Clinical Characterization and Prognostic Risk Factors of Susac Syndrome: A Retrospective Multicenter StudyLior Fuchs, Adi Wilf-Yarkoni, Hadar Kolb, et al.
Scientific Reports|December 9, 2022
Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritisHadas Stiebel-Kalish, Kerstin Rubarth, Karny Shouchane-Blum, et al.
Plos One|December 7, 2023
Effectiveness of oral prednisone tapering following intravenous methylprednisolone for acute optic neuritis in multiple sclerosisAdi Wilf-Yarkoni, Kristina Feldmann, Kerstin Rubarth, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 11, 2023
Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody diseaseItay Lotan, John J Chen, Yael Hacohen, et al.
Multiple Sclerosis and Related Disorders|July 25, 2025
Relapse and disability outcomes in incident MOGAD patients undergoing watchful waiting after onsetNanthaya Tisavipat, Adi Wilf-Yarkoni, Abdullah Al-Ani, et al.
Multiple Sclerosis and Related Disorders|October 17, 2022
Details and outcomes of a large cohort of MOG-IgG associated optic neuritisJohn J Chen, Eoin P Flanagan, M Tariq Bhatti, et al.
Frontiers in Immunology|July 18, 2024
Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT)Sara Samadzadeh, Rafl Adnan, Paulina Berglova, et al.
Multiple Sclerosis and Related Disorders|January 17, 2022
OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody-associated disease and Multiple Sclerosis: RNFL thickening in acute optic neuritis from MOGAD vs MSJohn J Chen, Elias S Sotirchos, Amanda D Henderson, et al.
Pageof 7